Theravance Biopharma (TBPH) Stock Research

Today

Theravance Biopharma reports Q2 revenue $20.7M, consensus $22.32M

TBPH

8:33 AM

Over a week ago

Theravance Biopharma just downgraded at H.C. Wainwright, here's why

TBPH

Jul 7, 7:36 AM

Zymeworks price target raised to $37 from $35 at Citi

Jun 30, 5:41 AM

Theravance Biopharma just downgraded at BTIG, here's why

TBPH

Jun 29, 9:36 AM

Morning Movers: Comcast surges after announcing spinoff of NBCUniversal

Jun 29, 9:04 AM

Theravance Biopharma just downgraded at JonesResearch, here's why

TBPH

Jun 29, 8:35 AM

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

Jun 29, 6:12 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M

Jun 29, 6:06 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share

Jun 29, 6:00 AM

Theravance Biopharma reports Q1 EPS (10c) vs. (17c) last year

TBPH

May 7, 8:35 AM

Theravance Biopharma price target raised by $3 at B. Riley, here's why

Apr 7, 8:27 AM

Theravance Biopharma price target raised by $2 at TD Cowen, here's why

TBPH

Mar 23, 8:53 AM

Theravance Biopharma reports Q4 EPS $1.15, consensus $1.10

TBPH

Mar 19, 8:33 AM

Theravance Biopharma options imply 3.2% move in share price post-earnings

TBPH

Mar 5, 3:11 PM

Theravance Biopharma downgraded at Oppenheimer after ampreloxetine miss

TBPH

Mar 5, 10:39 AM

Oppenheimer gets more bearish on Theravance Biopharma, downgrades shares

TBPH

Mar 5, 10:36 AM

Theravance Biopharma price target lowered by $12 at H.C. Wainwright, here's why

TBPH

Mar 4, 6:15 AM

Theravance Biopharma just downgraded at B. Riley, here's why

TBPH

Mar 4, 5:00 AM

What You Missed On Wall Street On Tuesday

+28

Mar 3, 4:13 PM

Theravance Biopharma price target lowered by $19 at BTIG, here's why

TBPH

Mar 3, 11:53 AM

Midday Fly By: Target earnings hit the mark, Elliott invests $1B in Pinterest

+25

Mar 3, 11:49 AM

Theravance Biopharma falls 28% to $13.55 in pre-market trading

TBPH

Mar 3, 8:56 AM

Theravance Biopharma trading resumes

TBPH

Mar 3, 8:50 AM

Theravance Biopharma implements cost reduction actions after study results

TBPH

Mar 3, 8:44 AM

Theravance Biopharma winding down ampreloxetine program after Phase 3 results

TBPH

Mar 3, 8:37 AM